Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
New Dosing Option Approved for Imfinzi in NSCLC, Bladder Cancer
Pegcetacoplan Gets Priority Review for Paroxysmal Nocturnal Hemoglobinuria
Manufacturing Deficiencies Delay Decision on Sutimlimab for Cold Agglutinin Disease
Finerenone NDA Submitted for Diabetic Kidney Disease
Novel Medication Relieves Pruritus in Hemodialysis Cases
Apabetalone Prevents CV Events in High-Risk Diabetic CKD
Nivolumab Plus Cabozantinib Under Review for Renal Cell Carcinoma
Glecaprevir and Pibrentasvir Aid HCV D+/R- Kidney Transplants
FDA Approves New Formulation of Ultomiris for PNH and aHUS
Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication
Generic Version of Ferriprox Now Available
Antidepressant, NSAID Identified as Culprits in SIADH Case
Factors Contributing to Darbepoetin Responsiveness in CKD
Tenapanor Under Review for Hyperphosphatemia in CKD
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1
Vadadustat Noninferior to Darbepoetin in CKD
Empagliflozin Beneficial in Heart Failure With Reduced Ejection Fraction
Guideline Updated for Nutrition in Chronic Kidney Disease